Evidence for off label prescribing - explore less, confirm more episode artwork

EPISODE · Mar 23, 2018 · 24 MIN

Evidence for off label prescribing - explore less, confirm more

from Medicine and Science from The BMJ · host The BMJ

When a new drug reaches market, the race is on to find more indications for its use - exploratory trials are set up, and positive results can lead to the off label prescriptions (eg Pregabalin for lower back pain. However, these initial indications are rarely confirmed with further, better quality, evidence. Jonathan Kimmelman is an associate professor at MCgill University in Canada, thinks it's time to explore less, and confirm more - and joins us to explain why. Read the full analysis: http://www.bmj.com/content/360/bmj.k959

NOW PLAYING

Evidence for off label prescribing - explore less, confirm more

0:00 24:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Medicine and Science from The BMJ?

This episode is 24 minutes long.

When was this Medicine and Science from The BMJ episode published?

This episode was published on March 23, 2018.

What is this episode about?

When a new drug reaches market, the race is on to find more indications for its use - exploratory trials are set up, and positive results can lead to the off label prescriptions (eg Pregabalin for lower back pain. However, these initial indications...

Can I download this Medicine and Science from The BMJ episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!